加味黃芪建中湯治療消化性潰瘍(脾胃虛寒證)臨床療效觀察

《加味黃芪建中湯治療消化性潰瘍(脾胃虛寒證)臨床療效觀察》由會(huì)員上傳分享，免費(fèi)在線閱讀，更多相關(guān)內(nèi)容在學(xué)術(shù)論文-天天文庫。

1、學(xué)位論文加味黃芪建中湯治療消化性潰瘍(脾胃虛寒證)臨床療效觀察胡業(yè)建指導(dǎo)教師姓名：鋈超主任醫(yī)師申請(qǐng)學(xué)位級(jí)別：亟±專業(yè)名稱：圭醫(yī)凼型堂論文提交時(shí)間：二O一二年五月中文摘要目的：通過加味黃芪建中湯治療消化性潰瘍(脾胃虛寒證)的臨床實(shí)驗(yàn)研究，觀察其臨床療效。方法：將符合診斷標(biāo)準(zhǔn)的50例病人隨機(jī)分為治療組和對(duì)照組。治療組患者為25例，對(duì)照組患者為25例。兩組病例一般資料、治療前癥狀積分基本相同，經(jīng)統(tǒng)計(jì)學(xué)處理，無顯著性差異意義，具有可比性。治療組以加味黃芪建中湯治療，對(duì)照組治療以奧美拉唑、阿莫西林、克拉霉素治療。比較治療前后的臨床癥狀改善情況。結(jié)果：(

2、1)臨床癥狀有效率治療組為88．00％，對(duì)照組為80．00％；胃鏡檢查的有效率治療組為92．00％，對(duì)照組88．00％。兩有效率，治療組和對(duì)照組比較無統(tǒng)計(jì)意義(P>0．05)。(2)治療組和對(duì)照組治療后各癥狀積分與治療前組內(nèi)比較均有統(tǒng)計(jì)學(xué)意義(P<0．05)。(3)治療組及對(duì)照組的患者在臨床研究過程中均未見不良反應(yīng)。結(jié)論：(1)治療組和對(duì)照組總有效率比較無顯著性差異。(2)兩組治療方法都能獲得較好的臨床療效，加味黃芪建中湯治療消化性潰瘍療效并不低于西藥(奧美拉唑、阿莫西林、克拉霉素)。關(guān)鍵詞：消化性潰瘍，加味黃芪建中湯，奧美拉唑，阿莫西林，克

3、拉霉素ABSTRACTobjective：ThroughmodifiedHuangqijianzhongDecoctioninthetreatmentofpepticulcer(spleendeficiencysyndrome)intheclinicalexperimentalresearch,toobserveitsclinicalcurativeeffectMethods：Willmeetthecriteriaforthediagnosisof50caseswererandomlydividedintotreatmentgroupandc

4、ontrolgroup．Patientsinthetreatmentgroupof25cases，25casesofpatientsofcontrolgroup．Generalmaterialsoftwogroupsbeforetreatment，symptomscoresarebasicallythesame，statistically,therewasnosignificantdifferenceinmeaning，withcomparable．ThetreatmentgroupweretreatedwithmodifiedHuangqi

5、jianzhongSouptreatment，grouptherapywithomeprazole，amoxicillin,clarithromycintherapy．Beforeandalterthetreatment，theclinicalsymptomimprovement．Results：(1)：tClinicalsymptomsofefficiencyinthetreatmentgroupWas88％，80％incontrolgroup；gastroscopyandtheefficiencyot92％inthetreatmentgr

6、oup，controlgroup88％．Twoefficiency,thetreatmentgroupandthecontrolgrouphadnostatisticalsignificance(P>O．05)．(2)：Thetreatmentgroupandcontrolgroupaftertreatmentthesymptomscoresandbeforetreatmentwithingroupcomparisonswerestatisticallysignificant(P

7、ntrolgroupofpatientsinclinicalcourseofstudyshowednoadversereaction．Conclusion：(1)：Thetreatmentgroupandthecontrolgroupinthetotalefficiencyofnosignificantdifferencecompared(2)：ThetwogroupsoftreatmentCangetbetterclinicalefficacy,modifiedHuangqijianzhongDecoctioninthetreatmento

8、fpepticulcerefficacyislowerthanWesternMedicine(omeprazole，amoxiciUin,clarithromyci